Core Scientific, Inc.
CORZ
$19.34
$1.287.09%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 70.79M | 84.95M | 101.93M | 116.67M | 119.30M |
| Total Other Revenue | 277.64M | 325.96M | 408.74M | 441.01M | 455.93M |
| Total Revenue | 348.43M | 410.91M | 510.67M | 557.68M | 575.23M |
| Cost of Revenue | 318.36M | 347.04M | 377.37M | 402.07M | 404.04M |
| Gross Profit | 30.07M | 63.87M | 133.30M | 155.61M | 171.18M |
| SG&A Expenses | 185.37M | 159.81M | 136.62M | 113.94M | 100.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -18.10M | 12.28M | 1.05M | 4.17M | 4.28M |
| Total Operating Expenses | 493.48M | 526.99M | 522.90M | 524.90M | 513.44M |
| Operating Income | -145.05M | -116.08M | -12.23M | 32.78M | 61.79M |
| Income Before Tax | -1.08B | -944.15M | -1.31B | -1.24B | -830.24M |
| Income Tax Expenses | 872.00K | 858.00K | 859.00K | 820.00K | 800.00K |
| Earnings from Continuing Operations | -1.08K | -945.00 | -1.32K | -1.25K | -831.04 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.08B | -945.00M | -1.32B | -1.25B | -831.04M |
| EBIT | -145.05M | -116.08M | -12.23M | 32.78M | 61.79M |
| EBITDA | -51.83M | -12.14M | 100.98M | 151.15M | 175.70M |
| EPS Basic | -1.99 | -6.46 | -5.37 | -5.28 | -4.21 |
| Normalized Basic EPS | -2.20 | -3.19 | -4.07 | -3.65 | -2.70 |
| EPS Diluted | -1.99 | -6.46 | -5.51 | -5.42 | -4.36 |
| Normalized Diluted EPS | -2.20 | -3.19 | -4.12 | -3.70 | -2.75 |
| Average Basic Shares Outstanding | 1.23B | 1.09B | 1.01B | 1.09B | 1.18B |
| Average Diluted Shares Outstanding | 1.23B | 1.09B | 1.06B | 1.14B | 1.23B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |